Achieve Life Sciences Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$6.30

-0.10 (-1.56%)

As of Jul 4, 2:08 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +406.2% upside

Low Target $22.93

Average Target $31.89

High Target $41.27

Current Price $6.30

Current
$6.30

Target
$31.89

$22.93 $31.89 avg $41.27

Scenario Analysis

Bear Case

$22.93

264.0%

Low target

Base Case

$31.89

+406.2%

Avg target

Bull Case

$41.27

+555.1%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$7.11

-11.4% from high

52-Week Low

$2.02

+212.7% from low

Target vs 52W High

$31.89

+348.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	-1.3%
AMGN Amgen Inc	Hold	44	50%	$190.87	-49.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+176.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-17.0%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-88.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-67.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-48.8%